232 related articles for article (PubMed ID: 29523953)
1. Comparison of three classifications for lymph node evaluation in patients undergoing total mesorectal excision for rectal cancer.
Fritzmann J; Contin P; Reissfelder C; Büchler MW; Weitz J; Rahbari NN; Ulrich AB
Langenbecks Arch Surg; 2018 Jun; 403(4):451-462. PubMed ID: 29523953
[TBL] [Abstract][Full Text] [Related]
2. lymph node ratio as a prognostic factor in patients with stage III rectal cancer treated with total mesorectal excision followed by chemoradiotherapy.
Kim YS; Kim JH; Yoon SM; Choi EK; Ahn SD; Lee SW; Kim JC; Yu CS; Kim HC; Kim TW; Chang HM
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):796-802. PubMed ID: 19289261
[TBL] [Abstract][Full Text] [Related]
3. Lymph node ratio and surgical quality are strong prognostic factors of rectal cancer: results from a single referral centre.
Leonard D; Remue C; Abbes Orabi N; van Maanen A; Danse E; Dragean A; Debetancourt D; Humblet Y; Jouret-Mourin A; Maddalena F; Medina Benites A; Scalliet P; Sempoux C; Van den Eynde M; De Schoutheete JC; Kartheuser A
Colorectal Dis; 2016 Jun; 18(6):O175-84. PubMed ID: 27128602
[TBL] [Abstract][Full Text] [Related]
4. Lymph node ratio is an independent prognostic factor in node positive rectal cancer patients treated with preoperative chemoradiotherapy followed by curative resection.
Zeng WG; Zhou ZX; Wang Z; Liang JW; Hou HR; Zhou HT; Zhang XM; Hu JJ
Asian Pac J Cancer Prev; 2014; 15(13):5365-9. PubMed ID: 25041003
[TBL] [Abstract][Full Text] [Related]
5. Impact of Lymph Node Ratio on Oncologic Outcomes in ypStage III Rectal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy followed by Total Mesorectal Excision, and Postoperative Adjuvant Chemotherapy.
Koo T; Song C; Kim JS; Kim K; Chie EK; Kang SB; Lee KW; Kim JH; Jeong SY; Kim TY
PLoS One; 2015; 10(9):e0138728. PubMed ID: 26381522
[TBL] [Abstract][Full Text] [Related]
6. Quantitative lymph node evaluation as an independent marker of long-term prognosis in stage III rectal cancer.
Vather R; Sammour T; Kahokehr A; Connolly A; Hill A
ANZ J Surg; 2011 Dec; 81(12):883-8. PubMed ID: 22507414
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Value of Lymph Node Ratio in Locally Advanced Rectal Cancer Patients After Preoperative Chemoradiotherapy Followed by Total Mesorectal Excision.
Zuo ZG; Zhang XF; Wang H; Liu QZ; Ye XZ; Xu C; Wu XB; Cai JH; Zhou ZH; Li JL; Song HY; Luo ZQ; Li P; Ni SC; Jiang L
Medicine (Baltimore); 2016 Mar; 95(9):e2988. PubMed ID: 26945418
[TBL] [Abstract][Full Text] [Related]
8. The prognostic value of lymph node ratio and updated TNM classification in rectal cancer patients with adequate versus inadequate lymph node dissection.
Junginger T; Goenner U; Lollert A; Hollemann D; Berres M; Blettner M
Tech Coloproctol; 2014 Sep; 18(9):805-11. PubMed ID: 24643761
[TBL] [Abstract][Full Text] [Related]
9. Metastatic lymph node ratio in stage III rectal cancer; prognostic significance in addition to the 7th edition of the TNM classification.
Dekker JW; Peeters KC; Putter H; Vahrmeijer AL; van de Velde CJ
Eur J Surg Oncol; 2010 Dec; 36(12):1180-6. PubMed ID: 20884164
[TBL] [Abstract][Full Text] [Related]
10. [Prognostic value of lymph node ratio staging system in stage III( rectal cancer following 30 Gy/10 f preoperative radiotherapy].
Wang L; Li Z; Li M; Peng Y; Gu J
Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Oct; 17(10):990-6. PubMed ID: 25341906
[TBL] [Abstract][Full Text] [Related]
11. The importance of lymph node retrieval and lymph node ratio following preoperative chemoradiation of rectal cancer.
La Torre M; Mazzuca F; Ferri M; Mari FS; Botticelli A; Pilozzi E; Lorenzon L; Osti MF; Marchetti P; Enrici RM; Ziparo V
Colorectal Dis; 2013 Jul; 15(7):e382-8. PubMed ID: 23581854
[TBL] [Abstract][Full Text] [Related]
12. [Prognostic value of lymph node ratio in survival of patients with stage III rectal cancer].
Zhu XW; Wu CS; Yuan SC
Zhonghua Zhong Liu Za Zhi; 2012 Jul; 34(7):506-9. PubMed ID: 22967468
[TBL] [Abstract][Full Text] [Related]
13. [The association of metastasis-related indexes of lymph nodes and the prognosis of stage N2b colorectal cancer patients].
Zheng W; Zhang L; Wu YL; Zhang HZ
Zhonghua Zhong Liu Za Zhi; 2018 Sep; 40(9):679-683. PubMed ID: 30293393
[No Abstract] [Full Text] [Related]
14. Prognostic value of lymph node ratios in node positive rectal cancer treated with preoperative chemoradiation.
Nadoshan JJ; Omranipour R; Beiki O; Zendedel K; Alibakhshi A; Mahmoodzadeh H
Asian Pac J Cancer Prev; 2013; 14(6):3769-72. PubMed ID: 23886180
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant therapy does not affect lymph node ratio in rectal cancer.
Chang KH; Kelly NP; Duff GP; Condon ET; Waldron D; Coffey JC
Surgeon; 2016 Oct; 14(5):270-3. PubMed ID: 26148760
[TBL] [Abstract][Full Text] [Related]
16. Log odds of positive lymph nodes is a superior prognostic indicator in stage III rectal cancer patients: A retrospective analysis of 17,632 patients in the SEER database.
Huang B; Chen C; Ni M; Mo S; Cai G; Cai S
Int J Surg; 2016 Aug; 32():24-30. PubMed ID: 27321382
[TBL] [Abstract][Full Text] [Related]
17. The prognostic value of lymph node ratio in a national cohort of rectal cancer patients.
Lykke J; Jess P; Roikjaer O;
Eur J Surg Oncol; 2016 Apr; 42(4):504-12. PubMed ID: 26856955
[TBL] [Abstract][Full Text] [Related]
18. Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial.
Fujita S; Akasu T; Mizusawa J; Saito N; Kinugasa Y; Kanemitsu Y; Ohue M; Fujii S; Shiozawa M; Yamaguchi T; Moriya Y;
Lancet Oncol; 2012 Jun; 13(6):616-21. PubMed ID: 22591948
[TBL] [Abstract][Full Text] [Related]
19. Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study.
O'Sullivan B; Huang SH; Su J; Garden AS; Sturgis EM; Dahlstrom K; Lee N; Riaz N; Pei X; Koyfman SA; Adelstein D; Burkey BB; Friborg J; Kristensen CA; Gothelf AB; Hoebers F; Kremer B; Speel EJ; Bowles DW; Raben D; Karam SD; Yu E; Xu W
Lancet Oncol; 2016 Apr; 17(4):440-451. PubMed ID: 26936027
[TBL] [Abstract][Full Text] [Related]
20. Comparison of staging between the old (6th edition) and new (7th edition) TNM classifications in advanced gastric cancer.
Kikuchi S; Futawatari N; Sakuramoto S; Katada N; Yamashita K; Shibata T; Nemoto M; Watanabe M
Anticancer Res; 2011 Jun; 31(6):2361-5. PubMed ID: 21737665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
